ICAP North America, Inc. – Trademark Portfolio
Entity Type: 03
ICAP North America, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 6 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include RESET. The owner is based in Jersey City, NJ.
Harborside Financial Center,1100 Plaza 5
Jersey City, NJ 07311
Showing of trademarks Trademarks
Trademark Classifications
ICAP North America, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does ICAP North America, Inc. have?
ICAP North America, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 3 cancelled.
What trademark classes does ICAP North America, Inc. file in?
ICAP North America, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 9 (Computers & Electronics), Class 35 (Advertising & Business). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are ICAP North America, Inc.'s most well-known trademarks?
ICAP North America, Inc.'s registered trademark portfolio includes well-known marks such as RESET. These are among 1 currently registered trademark in the portfolio.
What is ICAP North America, Inc.'s trademark registration success rate?
ICAP North America, Inc. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.